FMR1 and fragile X syndrome: Both assays are recommended to be performed as deletion at either end of a CGG-repeat expansion—reported in <1% of FXS cases—can prevent annealing of the FMR1 locus-specific primer, and result in drop-out of the expanded allele and failure to detect a true positive, if either one of these assays was applied alone [152].